SearchStrings |
1 | 7100 | 69.51 | &esrc=s |
2 | 149 | 1.46 | tropical journal of pharmaceutical resea... |
3 | 60 | 0.59 | tjpr |
4 | 29 | 0.28 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
5 | 25 | 0.24 | drug entrapment in niosomes |
6 | 23 | 0.23 | against carbon tetrachloride–induced |
7 | 23 | 0.23 | traditional medicinal plants used in son... |
8 | 21 | 0.21 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
9 | 21 | 0.21 | traditional methods of the use of medici... |
10 | 20 | 0.20 | http://www.tjpr.org/ |
11 | 19 | 0.19 | 1 |
12 | 18 | 0.18 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
13 | 17 | 0.17 | key enzyme producing salvianolic a, b in... |
14 | 14 | 0.14 | http://www.tjpr.org/vol1%20no2/okhamafe1... |
15 | 13 | 0.13 | validation+drug |
16 | 13 | 0.13 | mucin carrageenan |
17 | 13 | 0.13 | liver fibrosis predictores pdf 2013 |
18 | 13 | 0.13 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
19 | 13 | 0.13 | diversity of ocean life. tjpr |
20 | 12 | 0.12 | urtica dioica |
21 | 12 | 0.12 | poisonous snakes in nigeria |
22 | 12 | 0.12 | deinococcus radiodurans |
23 | 11 | 0.11 | cyp2d6*3 allele analysis structures pdf |
24 | 11 | 0.11 | how to prepare psyllium husk matric tabl... |
25 | 11 | 0.11 | mice mda in liver |
26 | 11 | 0.11 | deinococcus |
27 | 10 | 0.10 | african locust beans modified functional... |
28 | 10 | 0.10 | "umbelliprenin" filetype:pdf |
29 | 10 | 0.10 | benefit of green tea leaf pdf |
30 | 10 | 0.10 | tacca leontopetaloides |
31 | 10 | 0.10 | nano drug delivery system |
32 | 10 | 0.10 | (Google Cache) |
33 | 10 | 0.10 | the microwave-assisted extraction "of ac... |
34 | 10 | 0.10 | sem images of swellable tablets |
35 | 10 | 0.10 | http://www.tjpr.org/vol7_no2/7210pachuau... |
36 | 10 | 0.10 | what is validation in pharma |
37 | 10 | 0.10 | tropical journal of pharmaceutical resea... |
38 | 9 | 0.09 | 99350103 |
39 | 9 | 0.09 | assessment of antibacterial effects of f... |
40 | 9 | 0.09 | pharmaceutical validation |
41 | 9 | 0.09 | transdermal drug delivery system pdf?q=t... |
42 | 9 | 0.09 | http://www.tjpr.org/vol7_no1/718madan.pd... |
43 | 9 | 0.09 | trop j pharm res |
44 | 9 | 0.09 | brucea javanica fatty acid anticancer ag... |
45 | 8 | 0.08 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
46 | 8 | 0.08 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
47 | 8 | 0.08 | ames test |
48 | 8 | 0.08 | measurement bioinformatics in silico fil... |
49 | 8 | 0.08 | oral disintegrating tablets |
50 | 8 | 0.08 | normal range c3and c4 |
51 | 8 | 0.08 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
52 | 8 | 0.08 | &si=124514_psg_gcind |
53 | 8 | 0.08 | antioxidant in millet |
54 | 7 | 0.07 | topical arabidopsis extract uvb |
55 | 7 | 0.07 | snakes in nigeria |
56 | 7 | 0.07 | http://www.tjpr.org/vol7_no1/713behera.p... |
57 | 7 | 0.07 | http://www.tjpr.org/vol3_no1/33ikhuoria.... |
58 | 7 | 0.07 | medicinal properties of rose |
59 | 7 | 0.07 | http://www.tjpr.org/vol8_no2/2009_8_2_10... |
60 | 7 | 0.07 | orally dissolving tablet |
61 | 7 | 0.07 | pharmaceuticals validation |
62 | 7 | 0.07 | nanotechnology pdf for 10+2 |
63 | 7 | 0.07 | betahistine dihydrochloride bioavailabil... |
64 | 7 | 0.07 | tropical journal of pharmaceutical resea... |
65 | 7 | 0.07 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
66 | 7 | 0.07 | phytochemical screening of vernonia amyg... |
67 | 7 | 0.07 | http://www.tjpr.org/vol8_no4/2009_8_4_4_... |
68 | 7 | 0.07 | isolation of thrombin inhibitor from the... |
69 | 7 | 0.07 | antioxidant and hepatoprotective activit... |
70 | 7 | 0.07 | pharmaceutical process validation |
71 | 6 | 0.06 | validation pharmaceutical |
72 | 6 | 0.06 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
73 | 6 | 0.06 | antimicrobial activity of medicinal plan... |
74 | 6 | 0.06 | http://www.tjpr.org/vol7_no3/734_bashir.... |
75 | 6 | 0.06 | cache:http://www.tjpr.org/vol11_no2/inde... |
76 | 6 | 0.06 | tropical journal of pharmaceutical scien... |
77 | 6 | 0.06 | glipizde i.r. spectroscopy images |
78 | 6 | 0.06 | ebrahimzadeh |
79 | 6 | 0.06 | department quality procedure bulk drugs ... |
80 | 6 | 0.06 | herbal tooth paste formulation |
81 | 6 | 0.06 | assay of chloroquine phosphate using non... |
82 | 6 | 0.06 | microsphere pdf file |
83 | 6 | 0.06 | serum urea and creatinine level in diabe... |
84 | 6 | 0.06 | cache:http://www.tjpr.org/vol5_no1/volum... |
85 | 6 | 0.06 | www.tjpr.org |
86 | 6 | 0.06 | discuss drug permeation through the skin |
87 | 6 | 0.06 | manufacturing procedure of alkyd resin |
88 | 6 | 0.06 | chemical penetration enhancer |
89 | 6 | 0.06 | low c3 and high c4 |
90 | 6 | 0.06 | stability indicating method development ... |
91 | 6 | 0.06 | study on preparation of starch citrate.p... |
92 | 6 | 0.06 | separation+nanodrugs+pdf |
93 | 6 | 0.06 | nanotechnology in product design article... |
94 | 6 | 0.06 | gastroretentive drug delivery |
95 | 6 | 0.06 | ethnobotany pdf |
96 | 5 | 0.05 | types of validation in pharma |
97 | 5 | 0.05 | c3- complement (female) |
98 | 5 | 0.05 | chromosomal aberration |
99 | 5 | 0.05 | anti ulcer pdf file |
100 | 5 | 0.05 | developing drug delivery tools through n... |
101 | 5 | 0.05 | pill quickly dissolution in water pdf |
102 | 5 | 0.05 | permeation enhancers |
103 | 5 | 0.05 | http://www.tjpr.org/vol7_no2/726esimone.... |
104 | 5 | 0.05 | &source=web |
105 | 5 | 0.05 | microspheres preparation methods |
106 | 5 | 0.05 | http://tjpr.org/ |
107 | 5 | 0.05 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
108 | 5 | 0.05 | multiparticulate drug delivery system |
109 | 5 | 0.05 | validation in pharmaceutical industry pd... |
110 | 5 | 0.05 | kumar p, vasudeva s. enantio- and diaste... |
111 | 5 | 0.05 | method for prepare media for screening l... |
112 | 5 | 0.05 | complemet c3 and c 4 |
113 | 5 | 0.05 | tropical journal of phar |
114 | 5 | 0.05 | tropical journal |
115 | 5 | 0.05 | http://www.tjpr.org/vol8_no1/2009_8_1_8.... |
116 | 4 | 0.04 | low c4 level |
117 | 4 | 0.04 | http://www.tjpr.org/vol10_no3/2011_10_3_... |
118 | 4 | 0.04 | pharmaceutical care in nigeria |
119 | 4 | 0.04 | olayinka, b. o., olayinka, a. t., onaola... |
120 | 4 | 0.04 | phytochemical |
121 | 4 | 0.04 | orodispersible tablets fractional factor... |
122 | 4 | 0.04 | application of hplc in pharmacy filetype... |
123 | 4 | 0.04 | study on extraction and characterization... |
124 | 4 | 0.04 | pharmaceutical product development proce... |
125 | 4 | 0.04 | activities of flavonoids isolated from r... |
126 | 4 | 0.04 | druge delivery pdf |
127 | 4 | 0.04 | hplc chromatograms of sennosides |
128 | 4 | 0.04 | rai dore |
129 | 4 | 0.04 | http://www.tjpr.org/vol8_no1/2009_8_1_11... |
130 | 4 | 0.04 | poisonous snakes nigeria |
131 | 4 | 0.04 | content |
132 | 4 | 0.04 | stevia |
133 | 4 | 0.04 | peridontal strips |
134 | 4 | 0.04 | snakes of nigeria |
135 | 4 | 0.04 | herbal toothpaste formulation |
136 | 4 | 0.04 | emil endang kinetic |
137 | 4 | 0.04 | knowledge of home treatment of malaria a... |
138 | 4 | 0.04 | formulation of meloxicam tablet |
139 | 4 | 0.04 | validation in pharma |
140 | 4 | 0.04 | pharmaceutical validation |
141 | 4 | 0.04 | http://www.tjpr.org/vol8_no3/2009_8_3_9_... |
142 | 4 | 0.04 | nasaldrugdeliverysystem |
143 | 4 | 0.04 | polymer characterization by xrd |
144 | 4 | 0.04 | pharma validation |
145 | 4 | 0.04 | tropical journal of pharmaceutical scien... |
146 | 4 | 0.04 | artemisinin pdf |
147 | 4 | 0.04 | medicinal uses of breadfruit |
148 | 4 | 0.04 | dsc + polysaccharide + alginate nanopart... |
149 | 4 | 0.04 | calculation of drug concentration versus... |
150 | 4 | 0.04 | low c3 normal c4 |
151 | 4 | 0.04 | pharmacists primary health care in niger... |
152 | 4 | 0.04 | nano drug delivery paper.pdf |
153 | 4 | 0.04 | journal modified phosphorylated chitosan... |
154 | 4 | 0.04 | preparation and evaluation of matrix tab... |
155 | 4 | 0.04 | perbedaan hpmc k15 dan k100 |
156 | 4 | 0.04 | antipyretic pdf |
157 | 4 | 0.04 | kasim sakran abass |
158 | 4 | 0.04 | tropicaljournal of pharmaceutical resear... |
159 | 4 | 0.04 | aneamia with recrant abrtion |
160 | 4 | 0.04 | showing time of sesamum indicum |
161 | 4 | 0.04 | tropical journal of pharmacetical res |
162 | 4 | 0.04 | http://www.tjpr.org/vol8_no3/2009_8_3_7_... |
163 | 4 | 0.04 | what is the studies on microbial quality... |
164 | 4 | 0.04 | journal synthesis of a phosphorylated ch... |
165 | 3 | 0.03 | validation definition |
166 | 3 | 0.03 | quality survey of some brands of levoflo... |
167 | 3 | 0.03 | which specific solvent is used to dissol... |
168 | 3 | 0.03 | snakes nigeria |
169 | 3 | 0.03 | mucoadhesive drug |
170 | 3 | 0.03 | knowledge of diabetes mellitus in nigeri... |
171 | 3 | 0.03 | how to use multistage random sampling to... |
172 | 3 | 0.03 | quercetin kidney stone |
173 | 3 | 0.03 | adherence hypertension primary care sett... |
174 | 3 | 0.03 | anti-inflammatory and analgesic of indol... |
175 | 3 | 0.03 | penetration enhancers |
176 | 3 | 0.03 | mechanism action flavonoid, alkaloid and... |
177 | 3 | 0.03 | nasal drug delivery system |
178 | 3 | 0.03 | antimicrobial and antifungal properties ... |
179 | 3 | 0.03 | aceton extract against candida |
180 | 3 | 0.03 | pharmacognosy of gall wasps adleria gall... |
181 | 3 | 0.03 | &si=cnpfur6qqrgcfwxktaodhfwa_q |
182 | 3 | 0.03 | psyllium husk matric tablets with diclo... |
183 | 3 | 0.03 | antimicrobial activity of medicinal plan... |
184 | 3 | 0.03 | journal articles on counterfeit artesuna... |
185 | 3 | 0.03 | weight uniformity test of artesunate tab... |
186 | 3 | 0.03 | alkyd resin magnetically stirred |
187 | 3 | 0.03 | drug permeation through skin |
188 | 3 | 0.03 | analysis gs/ms of essential oil |
189 | 3 | 0.03 | mpdrs technology |
190 | 3 | 0.03 | komplemen c3 dan c4 serum |
191 | 3 | 0.03 | bioinformatics of resistance to antimala... |
192 | 3 | 0.03 | treatment of snake bites in nigeria |
193 | 3 | 0.03 | in process control of pharmaceuticals |
194 | 3 | 0.03 | &si=flvrunner |
195 | 3 | 0.03 | tropical journal of pharmaceutical |
196 | 3 | 0.03 | keyword , abstract :analysis in ms excel... |
197 | 3 | 0.03 | medicinal plant as aantimicrobial agent ... |
198 | 3 | 0.03 | pdf drug delivery systems |
199 | 3 | 0.03 | snakebite in nigeria |
200 | 3 | 0.03 | study on preparation and antibacterial o... |
201 | 3 | 0.03 | feng |
202 | 3 | 0.03 | n acetylcysteine and rheumatoid arthriti... |
203 | 3 | 0.03 | venomous sankes in nigeria |
204 | 3 | 0.03 | which is malaysian semi government uni i... |
205 | 3 | 0.03 | gastroretentive drug delivery system |
206 | 3 | 0.03 | type of penetration enhancers |
207 | 3 | 0.03 | journal of pharmaceutical research |
208 | 3 | 0.03 | new journals of annona raimondia for can... |
209 | 3 | 0.03 | evaluation of microspheres pdf |
210 | 3 | 0.03 | &si=begin-download |
211 | 3 | 0.03 | centaurea cyanus medicinal use pdf |
212 | 3 | 0.03 | novel levodapa gastroretentive: in vivo ... |
213 | 3 | 0.03 | journal phosphatidylcholine filetype:pdf |
214 | 3 | 0.03 | http://www.tjpr.org/vol10_no5/2011_10_5_... |
215 | 3 | 0.03 | formulation of microspheres pdf |
216 | 3 | 0.03 | aloe vera extraction unit pdf |
217 | 3 | 0.03 | gastroretantive drug delivery system pdf |
218 | 3 | 0.03 | diabetes, nigeria |
219 | 3 | 0.03 | validation techniques in pharmaceutical ... |
220 | 3 | 0.03 | normal c3 c4 levels |
221 | 3 | 0.03 | orally disintegrating tablets pdf |
222 | 3 | 0.03 | ikpoba okha local government pdf |
223 | 3 | 0.03 | phytochemical screening of flavonoids |
224 | 3 | 0.03 | high c3 and c4 complement levels relatio... |
225 | 3 | 0.03 | antimicrobial activity pdf |
226 | 3 | 0.03 | penetration enhancers transdermal |
227 | 3 | 0.03 | drug delivery nanotechnology |
228 | 3 | 0.03 | http://www.tjpr.org/vol9_no3/2010_9_3_8_... |
229 | 3 | 0.03 | colloiadal drug delivery system review ... |
230 | 3 | 0.03 | types of nasal inserts |
231 | 3 | 0.03 | poisonous snakes of nigeria |
232 | 3 | 0.03 | e.coli and sodium fluoride in toothpaste |
233 | 3 | 0.03 | http://www.tjpr.org/vol8_no2/2009_8_2_11... |
234 | 3 | 0.03 | questionnaire about pharmacist knowledge... |
235 | 3 | 0.03 | pdf validation process?q=pdf validation ... |
236 | 3 | 0.03 | isolation of staphylococcus aureus in ur... |
237 | 3 | 0.03 | bitter cola as antimicrobial agent |
238 | 3 | 0.03 | http://www.tjpr.org/vol7_no3/939_dey.pdf |
239 | 3 | 0.03 | removal of stratum corneum to aid transd... |
240 | 2 | 0.02 | disintegration of drug pdf |
241 | 2 | 0.02 | assay of chloroquine phosphate by non aq... |
242 | 2 | 0.02 | tropical journal of |
243 | 2 | 0.02 | reasons why self medication is higher in... |
244 | 2 | 0.02 | http://www.tjpr.org/content/issues.php |
245 | 2 | 0.02 | equipments used in pharma pdf |
246 | 2 | 0.02 | antidiarrheal activity of plants |
247 | 2 | 0.02 | what is a c-3 blood test used to disgnos... |
248 | 2 | 0.02 | list out the most populer arear in benin... |
249 | 2 | 0.02 | diseases that cause low c3 compliment le... |
250 | 2 | 0.02 | diuretic activity article pdf |
251 | 2 | 0.02 | www.preparation of some herbal medicine ... |
252 | 2 | 0.02 | antidiarrhoeal activity of medicinal pla... |
253 | 2 | 0.02 | anticonvulsant activity of herbal drugs |
254 | 2 | 0.02 | research articles on fast dissolving tab... |
255 | 2 | 0.02 | preparation and characterization of chit... |
256 | 2 | 0.02 | plant used in treatment of diarrhea acti... |
257 | 2 | 0.02 | validation protocol in pharma |
258 | 2 | 0.02 | effect of permwation enhancer on drug re... |
259 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
260 | 2 | 0.02 | coating of microspheres by solvent evapo... |
261 | 2 | 0.02 | apparatus for determining density of mic... |
262 | 2 | 0.02 | antibiotic susceptibility patterns of ur... |
263 | 2 | 0.02 | journals on benin city ground water puri... |
264 | 2 | 0.02 | effect of plant material on bacterial lo... |
265 | 2 | 0.02 | download review article on transdermal d... |
266 | 2 | 0.02 | validation of pharmaceutical product |
267 | 2 | 0.02 | pharma validation articles |
268 | 2 | 0.02 | lqc mqc hqc |
269 | 2 | 0.02 | dairy bacteriology and microbial analysi... |
270 | 2 | 0.02 | pharmaceutical validation?q=pharmaceutic... |
271 | 2 | 0.02 | pharmaceutical care plan american societ... |
272 | 2 | 0.02 | http://www.tjpr.org/vol7_no2/722adisa.pd... |
273 | 2 | 0.02 | high c3 and low c4 levels relationship |
274 | 2 | 0.02 | antimicrobial activity of rosmary agains... |
275 | 2 | 0.02 | validation pharma?q=validation pharma |
276 | 2 | 0.02 | polymeric micelles |
277 | 2 | 0.02 | http://www.tjpr.org/vol7_no4/749_ofokans... |
278 | 2 | 0.02 | chemical penetretion enhancers classific... |
279 | 2 | 0.02 | research on pasteurized milk |
280 | 2 | 0.02 | permeation enhancers pdf |
281 | 2 | 0.02 | tropical journal of |
282 | 2 | 0.02 | health promotion beliefs and practices b... |
283 | 2 | 0.02 | wells as a ground water source in edo st... |
284 | 2 | 0.02 | method vavalidation of hplc of meloxicam |
285 | 2 | 0.02 | losartan uv?q=losartan uv |
286 | 2 | 0.02 | isolation and molecular characterization... |
287 | 2 | 0.02 | hexidine mouthwash in nigeria |
288 | 2 | 0.02 | drug release pattern of controlled drug ... |
289 | 2 | 0.02 | class of analgesics and antipyretics/pdf |
290 | 2 | 0.02 | facility qualification & consideration o... |
291 | 2 | 0.02 | antimicrobial activity of hypericum popu... |
292 | 2 | 0.02 | reduced c3,c4 in renal disease |
293 | 2 | 0.02 | pharmacy care levels in hospitals in nig... |
294 | 2 | 0.02 | pharmaceutical equipment validation |
295 | 2 | 0.02 | concurrent validation in pharma |
296 | 2 | 0.02 | process validation.pdf |
297 | 2 | 0.02 | challanges faced by herbal medicine |
298 | 2 | 0.02 | antidiarrhea activity of medicinal plant |
299 | 2 | 0.02 | studies on artemisinin based combination... |
300 | 2 | 0.02 | http://www.ijres.org/indexing.html |
301 | 2 | 0.02 | transdermal delivery chemical |
302 | 2 | 0.02 | melting range time determination of supp... |
303 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
304 | 2 | 0.02 | erigeron floribundus |
305 | 2 | 0.02 | mucin enzyme |
306 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
307 | 2 | 0.02 | bioinformatics tools for drug discovery ... |
308 | 2 | 0.02 | abstract, keyword, issn or isbn "micros... |
309 | 2 | 0.02 | troica journa of pharmaceutical sciences |
310 | 2 | 0.02 | low complement c3 |
311 | 2 | 0.02 | drug permeation mechanisms |
312 | 2 | 0.02 | ado-odo/ota.pdf |
313 | 2 | 0.02 | honary- naghibi- tropical journal of pha... |
314 | 2 | 0.02 | consistenly low c3 66 c4 12 |
315 | 2 | 0.02 | blumea balsamifera |
316 | 2 | 0.02 | validation in drug manufacturing |
317 | 2 | 0.02 | research artical on stability indicating... |
318 | 2 | 0.02 | prevalence of malaria in local governmen... |
319 | 2 | 0.02 | pediatric low c3 level |
320 | 2 | 0.02 | particulate drug delivery system pdf |
321 | 2 | 0.02 | principles of environmrmenymtal science ... |
322 | 2 | 0.02 | what is process validation in pharmaceut... |
323 | 2 | 0.02 | pharmaceutical validation pdf file |
324 | 2 | 0.02 | methanol and action on body |
325 | 2 | 0.02 | application of nanotechnology in diagnos... |
326 | 2 | 0.02 | litrature of floating granules metronida... |
327 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
328 | 2 | 0.02 | targeted drug delivery and controlled re... |
329 | 2 | 0.02 | c3 c4 complement lupus diagnosis |
330 | 2 | 0.02 | activity antioxidant of ziziphus obtusif... |
331 | 2 | 0.02 | validations in pharmaceutical industry |
332 | 2 | 0.02 | use of tannins in wound healing pdf |
333 | 2 | 0.02 | literature of metronidazole floating gra... |
334 | 2 | 0.02 | how to prepare proniosome with ether inj... |
335 | 2 | 0.02 | high c3 and c4 complement levels table |
336 | 2 | 0.02 | trend validation in pharmaceutical |
337 | 2 | 0.02 | spontaneous reporting of adverse drug re... |
338 | 2 | 0.02 | nanotechnology and drug delivery part 1 |
339 | 2 | 0.02 | http://www.tjpr.org/vol12_no4/2013_12_4_... |
340 | 2 | 0.02 | a short reveiw on litrature of conventio... |
341 | 2 | 0.02 | multi unit particulate system |
342 | 2 | 0.02 | methylene blue test for detect pasturiza... |
343 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
344 | 2 | 0.02 | plants of diuretic pdf?q=plants of diure... |
345 | 2 | 0.02 | prevalidation activities & protocol prep... |
346 | 2 | 0.02 | nigerian snakes |
347 | 2 | 0.02 | controlled release drugs evaluation |
348 | 2 | 0.02 | the effect of whey protein on glutathion... |
349 | 2 | 0.02 | serum c3 and c4 levels |
350 | 2 | 0.02 | normal values of serum complements by wh... |
351 | 2 | 0.02 | major challanges in herbal devolopment |
352 | 2 | 0.02 | filetype:pdf jurnal staphylococcus |
353 | 2 | 0.02 | s honary, k ghajar, p khazaeli and p sha... |
354 | 2 | 0.02 | drug permeation through the skin |
355 | 2 | 0.02 | drug development design and evaluation f... |
356 | 2 | 0.02 | diabetes adherence yahaya |
357 | 2 | 0.02 | serum complement c3 c4 levels |
358 | 2 | 0.02 | serum c3 c4 |
359 | 2 | 0.02 | comparition of aqueous and methanol extr... |
360 | 2 | 0.02 | alt ast extract pdf |
361 | 2 | 0.02 | tropical pharmaceutical journal |
362 | 2 | 0.02 | idowu. et al(1998) |
363 | 2 | 0.02 | green nanotechnology in pharma pdf |
364 | 2 | 0.02 | 2722f7e4889252d9592623278f35861e |
365 | 2 | 0.02 | what is manufacture validation?q=what is... |
366 | 2 | 0.02 | non paid journal of pharmaceutical |
367 | 2 | 0.02 | urea skin penetration time |
368 | 2 | 0.02 | slugging aspirin |
369 | 2 | 0.02 | rp hplc of meloxicam |
370 | 2 | 0.02 | pakistani herbs filetype:pdf |
371 | 2 | 0.02 | in vitro percutaneous penetration studi... |
372 | 2 | 0.02 | iaa gc ms |
373 | 2 | 0.02 | pdf on what is antifungal activity |
374 | 2 | 0.02 | antidiare activiti.pdf |
375 | 2 | 0.02 | suppository bases pdf |
376 | 2 | 0.02 | profil spektra furosemid |
377 | 2 | 0.02 | overview article facility validation ph... |
378 | 2 | 0.02 | nanotechnology applications for clean wa... |
379 | 2 | 0.02 | fn |
380 | 2 | 0.02 | what happens in a pharmaceutical environ... |
381 | 2 | 0.02 | multiparticulate system |
382 | 2 | 0.02 | etnobotanical methodology by sk jain?q=e... |
383 | 2 | 0.02 | write the governing differential equatio... |
384 | 2 | 0.02 | http://www.tjpr.org/vol10_no2/2011_10_2_... |
385 | 2 | 0.02 | complement c4 serum |
386 | 2 | 0.02 | acidisol?q=acidisol |
387 | 2 | 0.02 | zidovudine pdf |
388 | 2 | 0.02 | permeation enhancer |
389 | 2 | 0.02 | mean apperture in sieve analysis |
390 | 2 | 0.02 | medicinal uses of combretum molle pdf |
391 | 2 | 0.02 | ipqa pdf torrent |
392 | 2 | 0.02 | literature of conventional dosage form |
393 | 2 | 0.02 | complement c3 + low |
394 | 2 | 0.02 | microsphere's of paracetamol.com |
395 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
396 | 2 | 0.02 | graphs on the effect of atropine on rats... |
397 | 2 | 0.02 | "drug release" "physical state" microsph... |
398 | 2 | 0.02 | orodispersible tablet pdf |
399 | 2 | 0.02 | taha jiangnan |
400 | 2 | 0.02 | glycyrrhiza glabra hair growth |
401 | 2 | 0.02 | elevated complement c4 serum |
402 | 2 | 0.02 | "jin-he jiang" |
403 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
404 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
405 | 2 | 0.02 | serum protein complement c3 |
406 | 2 | 0.02 | prevalidation activities & proocol prepa... |
407 | 2 | 0.02 | liquid parafin for solvent evaporation |
408 | 2 | 0.02 | how to do process validation of formulat... |
409 | 2 | 0.02 | amoxcillin and caffeine |
410 | 2 | 0.02 | validation of equipment in pharmaceutica... |
411 | 2 | 0.02 | spectrophotometry method uv vis article |
412 | 2 | 0.02 | eudragit |
413 | 2 | 0.02 | pharmaceutical validation pdf |
414 | 2 | 0.02 | low c3 and c4 |
415 | 2 | 0.02 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
416 | 2 | 0.02 | bioactive in patchouli journal |
417 | 2 | 0.02 | how to write an editorial on sustainable... |
418 | 2 | 0.02 | formulation and evaluation of acetaminop... |
419 | 2 | 0.02 | analysis of benin city ground water trea... |
420 | 2 | 0.02 | what is the pharmacokinetic of gentamici... |
421 | 2 | 0.02 | tropical j of |
422 | 2 | 0.02 | the awareness level of malaria among mot... |
423 | 2 | 0.02 | adverse drug reactions of artemisinin |
424 | 2 | 0.02 | aceclofenac dissolution of sustain reles... |
425 | 2 | 0.02 | penetration enhancer |
426 | 2 | 0.02 | more knowledge of malaria in pdf form |
427 | 2 | 0.02 | butchi@mail.telepac.pt |
428 | 2 | 0.02 | uses of hygrophila spinosa plant leaves |
429 | 2 | 0.02 | bus driver attitude affect performance |
430 | 2 | 0.02 | results on antinicrobial activity pdf |
431 | 2 | 0.02 | evaluation of toothpaste safety studies |
432 | 2 | 0.02 | antidiarrhoeal drugs dosage pdg |
433 | 2 | 0.02 | what is validation in drug mfg |
434 | 2 | 0.02 | shimul halder albumsongmpthree@com |
435 | 2 | 0.02 | preparation and evaluation of microsphar... |
436 | 2 | 0.02 | kpr chowdhari ethyl cellulose microspher... |
437 | 2 | 0.02 | introduction to bitter kola |
438 | 2 | 0.02 | gentalek injection |
439 | 2 | 0.02 | controlled release drug delivery system |
440 | 2 | 0.02 | curent reasearch on gloriosa superba |
441 | 2 | 0.02 | prepare and evaluate microsphere of para... |
442 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
443 | 2 | 0.02 | multiple unit particulate system |
444 | 2 | 0.02 | how to perform validation testing on pha... |
445 | 2 | 0.02 | drinking behavior and attitude among nig... |
446 | 2 | 0.02 | cache:http://www.tjpr.org/vol13_no1/inde... |
447 | 2 | 0.02 | isaac karimi |
448 | 2 | 0.02 | challenges of implementation of pharmace... |
449 | 2 | 0.02 | pharmacutical validation |
450 | 2 | 0.02 | journal co precipitation and complexatio... |
451 | 2 | 0.02 | evaluation of groundwater potential in e... |
452 | 2 | 0.02 | drug permeation through the skin. |
453 | 2 | 0.02 | brucella spondylitis |
454 | 2 | 0.02 | anticholinesterase pdf |
455 | 2 | 0.02 | abstract of microbiological quality of ... |
456 | 2 | 0.02 | serum c3?q=serum c3 |
457 | 2 | 0.02 | preparation and drug content of micropar... |
458 | 2 | 0.02 | low c3 and c4 levels |
459 | 2 | 0.02 | http://www.tjpr.org/vol6_no3/638sharma.p... |
460 | 2 | 0.02 | beesoo sponge |
461 | 2 | 0.02 | antibiotics fermentation + medium soybea... |
462 | 2 | 0.02 | newbouldia laevis pdf |
463 | 2 | 0.02 | knowledge of malaria prevention strateg... |
464 | 2 | 0.02 | chemical enhancers transdermal delivery |
465 | 2 | 0.02 | artemisinin advers or side effects |
466 | 2 | 0.02 | oral disintegrating tablet |
467 | 2 | 0.02 | mechanism action of absorption enhancer ... |
468 | 2 | 0.02 | ground water assesment in parts of benin... |
469 | 2 | 0.02 | excel table, issn, keyword, abstract fil... |
470 | 2 | 0.02 | research in department of chimistry yuna... |
471 | 2 | 0.02 | prescription and dispensing practices in... |
472 | 2 | 0.02 | pharmaceutical despensing questions |
473 | 2 | 0.02 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
474 | 2 | 0.02 | history nanomedicine nanotechnology ppt ... |
475 | 2 | 0.02 | elevated esr and complement c4 |
476 | 2 | 0.02 | discuss drug permeation on the skin |
477 | 2 | 0.02 | stratum corneum bypass or removed |
478 | 2 | 0.02 | reported case of paracetamol and non-ste... |
479 | 2 | 0.02 | proniosomes?q=proniosomes |
480 | 2 | 0.02 | ethonobotany pdf |
481 | 2 | 0.02 | terminalia glaucescens+ pdf+journal |
482 | 2 | 0.02 | pharmaceutical industry process validati... |
483 | 2 | 0.02 | nigerian journal on clinical manifestati... |
484 | 2 | 0.02 | mechanism and benefit of floating drug d... |
485 | 2 | 0.02 | excil and tropical journal of pharmaceut... |
486 | 2 | 0.02 | development and validation of pharmaceut... |
487 | 2 | 0.02 | antibacterial interaction of crude metha... |
488 | 1 | 0.01 | vallesia glabra sonora |
489 | 1 | 0.01 | nsaids abuse prevalence, students |
490 | 1 | 0.01 | isopropyl myristate miscibility in sesam... |
491 | 1 | 0.01 | stages of producing a pharmaceutical dru... |
492 | 1 | 0.01 | chemical enhancers |
493 | 1 | 0.01 | c3 y c4 why are important |
494 | 1 | 0.01 | c4 serum high |
495 | 1 | 0.01 | ec7a34f916655d4c7cfc71bb29db4480 |
496 | 1 | 0.01 | what is mean by change control and devia... |
497 | 1 | 0.01 | tropical j of pha |
498 | 1 | 0.01 | 2dc4552421586f6deb544cd7fc87db1a |
499 | 1 | 0.01 | &ptb=e6e5b7c5-cfcb-476a-8652-3ba9de0a826... |
500 | 1 | 0.01 | c3 c4 level |
501 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
502 | 1 | 0.01 | factors affecting absorption through tdd... |
503 | 1 | 0.01 | full text+stevia rebaudiana+extract |
504 | 1 | 0.01 | working dose of l ascorbic acid in k562 ... |
505 | 1 | 0.01 | brine shrimp lethality test |
506 | 1 | 0.01 | drug delivery and coatings drug release ... |
507 | 1 | 0.01 | nebivolol |
508 | 1 | 0.01 | measurment of c3 and c4 detect? |
509 | 1 | 0.01 | jurnal interaksi farmasetik |
510 | 1 | 0.01 | interaction of coffee with drugs journal |
511 | 1 | 0.01 | ppt on validation guidelines for pharmac... |
512 | 1 | 0.01 | sennosides usp evaluation |
513 | 1 | 0.01 | awareness of malaria prevention strategi... |
514 | 1 | 0.01 | toothpaste manufacturing.pdf |
515 | 1 | 0.01 | pdf defination in pharmaceautical proces... |
516 | 1 | 0.01 | novelties in packaging for novel drug de... |
517 | 1 | 0.01 | review article on nasal insert |
518 | 1 | 0.01 | recent research on the effect of termina... |
519 | 1 | 0.01 | sop process design for pharmaceuticals |
520 | 1 | 0.01 | definition-pharmaceutics &pharmaceutical... |
521 | 1 | 0.01 | cefuroxime axetil bulk density |
522 | 1 | 0.01 | c3andc4 |
523 | 1 | 0.01 | checklist for generic drug development f... |
524 | 1 | 0.01 | dsc graph of pure tenoxicam drug |
525 | 1 | 0.01 | how avtard work |
526 | 1 | 0.01 | importance of validation in pharmaceutic... |
527 | 1 | 0.01 | microbial quality of milk done in ethiop... |
528 | 1 | 0.01 | microorganism in tablets pdf |
529 | 1 | 0.01 | literature of floating granules metronid... |
530 | 1 | 0.01 | installerex facebook?q=installerex faceb... |
531 | 1 | 0.01 | lipid disruption penetration enhancers |
532 | 1 | 0.01 | fast disintegrating tablets |
533 | 1 | 0.01 | gliclazide |
534 | 1 | 0.01 | floating tablets using hydroxypropyl met... |
535 | 1 | 0.01 | hplc combined method of artemether&lumef... |
536 | 1 | 0.01 | progress in controlled gastroretentive d... |
537 | 1 | 0.01 | osmotic tablet |
538 | 1 | 0.01 | professors of pharmacy in nigeria |
539 | 1 | 0.01 | nanotechnology based delivery system can... |
540 | 1 | 0.01 | nano technology + delivery system |
541 | 1 | 0.01 | nanotechnology in medicinal plants pdf |
542 | 1 | 0.01 | recent applications of dna microarray 20... |
543 | 1 | 0.01 | reported case of paracetamol and non-ste... |
544 | 1 | 0.01 | tropica journal pharmacetical sciences |
545 | 1 | 0.01 | non aqueous titration of chloroquine pho... |
546 | 1 | 0.01 | low c4 and lupus |
547 | 1 | 0.01 | knowledge about the effect of substance ... |
548 | 1 | 0.01 | lupus nephritis complement levels |
549 | 1 | 0.01 | artemisia essential oil |
550 | 1 | 0.01 | capsanthin alanine amino transferase |
551 | 1 | 0.01 | differential diagnosis low complement |
552 | 1 | 0.01 | transdermal drug delivery coconut oil |
553 | 1 | 0.01 | orodispersible tablet |
554 | 1 | 0.01 | penetration enhancers pdf |
555 | 1 | 0.01 | nephritis c 3 |
556 | 1 | 0.01 | microbial quality of medicinal plant mat... |
557 | 1 | 0.01 | priscription patern of hypertensive d... |
558 | 1 | 0.01 | validation of drug process pdf file |
559 | 1 | 0.01 | anti- inflammatory effect of extract, pd... |
560 | 1 | 0.01 | low c4 complement normal c3 |
561 | 1 | 0.01 | c3 and c4 deficiency lupus |
562 | 1 | 0.01 | tropical journal of pharmace |
563 | 1 | 0.01 | validation process for sterile products ... |
564 | 1 | 0.01 | antimicrobial activity of garcinia kola |
565 | 1 | 0.01 | 4cb6e6750c5582f66ae085688e0cdbdd |
566 | 1 | 0.01 | what mathematical method for drug distri... |
567 | 1 | 0.01 | mic methods for antifungal activity of ... |
568 | 1 | 0.01 | microporous memberane controlled drug de... |
569 | 1 | 0.01 | microbial evaluation of herbal preparati... |
570 | 1 | 0.01 | multiparticulate drug delivery systems f... |
571 | 1 | 0.01 | gentamicin induced nephrotoxicity |
572 | 1 | 0.01 | fast disintegrating tablets research art... |
573 | 1 | 0.01 | how to evaluate pharmacy function? |
574 | 1 | 0.01 | guignardia |
575 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
576 | 1 | 0.01 | proniosomes |
577 | 1 | 0.01 | phytohormone trees |
578 | 1 | 0.01 | olea europaea en colesterol 2013 |
579 | 1 | 0.01 | disintegration test for orodispersible t... |
580 | 1 | 0.01 | borneol distillation |
581 | 1 | 0.01 | degradation in hplc meaning |
582 | 1 | 0.01 | liver ccl4 |
583 | 1 | 0.01 | sample reponse for long clinic wait time |
584 | 1 | 0.01 | reported case of paracetamol and non-ste... |
585 | 1 | 0.01 | physiochemical and powder properties of ... |
586 | 1 | 0.01 | problem of ethnobotany |
587 | 1 | 0.01 | why do c3 and c4 complements in renal di... |
588 | 1 | 0.01 | tea wilson & clifford download |
589 | 1 | 0.01 | thesis on controlled release tablets pdf |
590 | 1 | 0.01 | &si=clqs8ifhg7ocfff04godlg0aha |
591 | 1 | 0.01 | antimicrobial activity of <i>tamar... |
592 | 1 | 0.01 | eniojukan and adeniyi |
593 | 1 | 0.01 | cefixime nanoparticles |
594 | 1 | 0.01 | complement levels c3 c4 |
595 | 1 | 0.01 | why is chloroquine phosphate used for no... |
596 | 1 | 0.01 | reserpine pdf |
597 | 1 | 0.01 | what is sub-g1 phase formation in human ... |
598 | 1 | 0.01 | &ptb=529a3bc6-3412-4e2f-bb01-d91aec60b27... |
599 | 1 | 0.01 | intra pharma benin |
600 | 1 | 0.01 | akmal djamaan jurnal online |
601 | 1 | 0.01 | pharmaceutical process validation protoc... |
602 | 1 | 0.01 | osmotic tabkets pdf |
603 | 1 | 0.01 | preparation and evaluation of microparti... |
604 | 1 | 0.01 | ankur gupta, sunil kumar prajapati, m ba... |
605 | 1 | 0.01 | alstonia boonei yoruba use |
606 | 1 | 0.01 | analysis of plant amino acids |
607 | 1 | 0.01 | antimicrobial activity of pyrazole pdf |
608 | 1 | 0.01 | atomic weight of chitosan |
609 | 1 | 0.01 | adverse effect of act |
610 | 1 | 0.01 | united arab emirates attitudes clinical ... |
611 | 1 | 0.01 | transdermal drug delivery |
612 | 1 | 0.01 | uniben school of pharmacy |
613 | 1 | 0.01 | effect of methacrylate polymers on swell... |
614 | 1 | 0.01 | government intervention towards pharmacy |
615 | 1 | 0.01 | low c3 and c4 complement levels in lupus |
616 | 1 | 0.01 | mouth dissolving tablets advantage hepat... |
617 | 1 | 0.01 | mups technology for 24 hours release pat... |
618 | 1 | 0.01 | molar mass chitosan |
619 | 1 | 0.01 | harmful microbial in liquid milk produc... |
620 | 1 | 0.01 | vit b complex in rats, pdf |
621 | 1 | 0.01 | honary, s.; hoseinzadeh, b.; shalchian,... |
622 | 1 | 0.01 | concepts of validation pdf |
623 | 1 | 0.01 | uses of diethyl ether pdf |
624 | 1 | 0.01 | reported case of paracetamol and non-ste... |
625 | 1 | 0.01 | prescribed medication use and road traff... |
626 | 1 | 0.01 | poisonous snakes in eastern nigeria |
627 | 1 | 0.01 | protocol for machine line suitability tr... |
628 | 1 | 0.01 | nigeria pharmaceutics journals |
629 | 1 | 0.01 | patient’s adherence to treatment and k... |
630 | 1 | 0.01 | calcium alginate beads pdf |
631 | 1 | 0.01 | atherosclerosis in nigeria |
632 | 1 | 0.01 | c3 and c4 levels in sle |
633 | 1 | 0.01 | adibe et al effect of occupational facto... |
634 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
635 | 1 | 0.01 | tropical journal of pharmaceutical res... |
636 | 1 | 0.01 | saliva medicinal leech |
637 | 1 | 0.01 | protective effects of green tea extracts... |
638 | 1 | 0.01 | sensitivity and responsiveness of health... |
639 | 1 | 0.01 | nanotechnology in liver drug delivery sy... |
640 | 1 | 0.01 | microbial quality of acidophilus milk |
641 | 1 | 0.01 | multiparticulate |
642 | 1 | 0.01 | pdf toothpaste |
643 | 1 | 0.01 | pharmaceutical validation process |
644 | 1 | 0.01 | african herbs vol 1 pdf |
645 | 1 | 0.01 | validation of pharmaceutical process,equ... |
646 | 1 | 0.01 | register?s=register |
647 | 1 | 0.01 | poison snakes in nigeria |
648 | 1 | 0.01 | snakes found in nigeria |
649 | 1 | 0.01 | dissolution of artemether and lumefantri... |
650 | 1 | 0.01 | caregivers knowledge on malaria |
651 | 1 | 0.01 | design development productn nd evaluatio... |
652 | 1 | 0.01 | low c3 and c4 serum levels |
653 | 1 | 0.01 | lupus and c3 c4 |
654 | 1 | 0.01 | what is the c4 test for lupus/ |
655 | 1 | 0.01 | saurabh sharma arun nanda |
656 | 1 | 0.01 | terminalia glaucescens and the lungs+pdf |
657 | 1 | 0.01 | pdf fast dissolving tablets |
658 | 1 | 0.01 | nanotechnology in drug delivery pdf |
659 | 1 | 0.01 | anticonvulsant effects of extract |
660 | 1 | 0.01 | journal adherence to prevent hypertensio... |
661 | 1 | 0.01 | indian pharmacoepia monograph on artheme... |
662 | 1 | 0.01 | meronem versus tazocine |
663 | 1 | 0.01 | androderm patch placement |
664 | 1 | 0.01 | bijen kıvcak |
665 | 1 | 0.01 | www.tjpr.orq |
666 | 1 | 0.01 | idowu et al |
667 | 1 | 0.01 | decreased c3 and c4 serum complement |
668 | 1 | 0.01 | knowledge of malaria fever by caregivers... |
669 | 1 | 0.01 | measuring complement levels sle |
670 | 1 | 0.01 | elevated c4 compliment normal c3 |
671 | 1 | 0.01 | cox-2/forward/ |
672 | 1 | 0.01 | anticancer in plant extracts pdf |
673 | 1 | 0.01 | antioxidant property of balanite aegypti... |
674 | 1 | 0.01 | overlay inoculum susceptibility disc met... |
675 | 1 | 0.01 | pharmacy and pharmaceutical process pdf |
676 | 1 | 0.01 | to prepare and evaluate microsphere by s... |
677 | 1 | 0.01 | ‫nano drug delivery pdf |
678 | 1 | 0.01 | hplc analysis of phenolphthalein |
679 | 1 | 0.01 | gastroretentive drug delivery system pdf |
680 | 1 | 0.01 | complete osd cleaning validation approve... |
681 | 1 | 0.01 | chemical properties of pyrazoline |
682 | 1 | 0.01 | controlled release delivery system |
683 | 1 | 0.01 | low c3 and nephritis |
684 | 1 | 0.01 | international medical university malaysi... |
685 | 1 | 0.01 | orally disintegrating tablets, bioequiva... |
686 | 1 | 0.01 | nigerian snakebite |
687 | 1 | 0.01 | osteoporosis + knowledge +students |
688 | 1 | 0.01 | international jurnal nsaid case report |
689 | 1 | 0.01 | microbial degradation of dosage form |
690 | 1 | 0.01 | effect extract in apoptosis using flow c... |
691 | 1 | 0.01 | doxorubicin hplc mobile phase |
692 | 1 | 0.01 | how does drug penetrate in transdermal |
693 | 1 | 0.01 | antioxidative and hepatoprotective activ... |
694 | 1 | 0.01 | chinedu valentine eze |
695 | 1 | 0.01 | avicel 101 pdf |
696 | 1 | 0.01 | complement c3 c4 |
697 | 1 | 0.01 | tetrapleura tetraptera in liver cacinome... |
698 | 1 | 0.01 | raymond ozolua |
699 | 1 | 0.01 | preparation, characterization and antiba... |
700 | 1 | 0.01 | prescribed medicine in case of escherich... |
701 | 1 | 0.01 | transdermal application hormones "urea" |
702 | 1 | 0.01 | yuejin hua |
703 | 1 | 0.01 | chalcone activity synthesis |
704 | 1 | 0.01 | antimicrobial synthesis |
705 | 1 | 0.01 | histology of cedrus deodar |
706 | 1 | 0.01 | formulation considerations of fast disin... |
707 | 1 | 0.01 | eddouks m, maghrani m, zeggwagh na; mich... |
708 | 1 | 0.01 | euchrestaflavanone a |
709 | 1 | 0.01 | tropical journal of pharmaceutical |
710 | 1 | 0.01 | umar farooq, jiangnan university |
711 | 1 | 0.01 | types of snakes in nigeria forest |
712 | 1 | 0.01 | medication error study done in pakistan ... |
713 | 1 | 0.01 | ketoprofen patch dissolution 24 hours |
714 | 1 | 0.01 | nanostructures vaccines |
715 | 1 | 0.01 | metowojo, k., agbonon, a., eklu-gadegbek... |
716 | 1 | 0.01 | microsponge pdf |
717 | 1 | 0.01 | pdf for guidelines for drug management o... |
718 | 1 | 0.01 | particulate drug delivery |
719 | 1 | 0.01 | t?s=t |
720 | 1 | 0.01 | rakesh formulation of sustained release ... |
721 | 1 | 0.01 | research on drug rdug interaction in ped... |
722 | 1 | 0.01 | pdf central composite tablet |
723 | 1 | 0.01 | low serum c4 |
724 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
725 | 1 | 0.01 | introduction to nanotechnology wikipidia |
726 | 1 | 0.01 | multiple unit beads system |
727 | 1 | 0.01 | nanotech approaches to drug deliver y a... |
728 | 1 | 0.01 | c3 c4 levels lupus |
729 | 1 | 0.01 | validation drug manufacturer |
730 | 1 | 0.01 | normal levels of c3 and c4 |
731 | 1 | 0.01 | microscopy of the lea erigeron floribund... |
732 | 1 | 0.01 | orally disintegrating tablets: a review ... |
733 | 1 | 0.01 | solvent evaporation method pdf |
734 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
735 | 1 | 0.01 | mannitol aloe |
736 | 1 | 0.01 | maximum wavelength for analysis phosphat... |
737 | 1 | 0.01 | olea europaea |
738 | 1 | 0.01 | tjpr%d0 |
739 | 1 | 0.01 | perception in clinical pharmacy service ... |
740 | 1 | 0.01 | melia azedarach, urolithiasis |
741 | 1 | 0.01 | low c3 found in which renal disease |
742 | 1 | 0.01 | microbial analysis of some medicinal pla... |
743 | 1 | 0.01 | endophytic fungi” |
744 | 1 | 0.01 | validation in pharma production |
745 | 1 | 0.01 | cassia occidentalis pdf |
746 | 1 | 0.01 | floating microsphere of acyclovir pdf |
747 | 1 | 0.01 | international conference of harmonisatio... |
748 | 1 | 0.01 | why is bacteria from the mouth is used f... |
749 | 1 | 0.01 | solubilitysalbutamol sulphatetheophyllin... |
750 | 1 | 0.01 | types of snakes in nigeria pdf |
751 | 1 | 0.01 | is malaria a caregiver |
752 | 1 | 0.01 | isolation of (-)-patchouli alcohol from ... |
753 | 1 | 0.01 | microspheres sterilization method |
754 | 1 | 0.01 | medicinal plants used in biotechnology |
755 | 1 | 0.01 | parameter, criteria, process, ipc of cle... |
756 | 1 | 0.01 | antipyretic activities of plant extracts... |
757 | 1 | 0.01 | albino rats |
758 | 1 | 0.01 | flavanoids antimicrobial |
759 | 1 | 0.01 | development of entric coated tablets wi... |
760 | 1 | 0.01 | disintegrating buccal tablets excipients... |
761 | 1 | 0.01 | c3 vs c4 in sle |
762 | 1 | 0.01 | application natural mucoadhessive polyme... |
763 | 1 | 0.01 | values of teac for bsa |
764 | 1 | 0.01 | uv spectrophotometric method development |
765 | 1 | 0.01 | what is the effect of combining of two a... |
766 | 1 | 0.01 | rabbit and organ and enzyme and extract |
767 | 1 | 0.01 | melanin effects on cancer pdf |
768 | 1 | 0.01 | oral insulin drug |
769 | 1 | 0.01 | urea for transdermal delivery |
770 | 1 | 0.01 | rosas-rodriguez amino acid determination... |
771 | 1 | 0.01 | incress serom albumin+flavonoids+rat"pdf... |
772 | 1 | 0.01 | green chemistry pdf |
773 | 1 | 0.01 | in situ forming implants degradation |
774 | 1 | 0.01 | basic raw material for chloroquin and th... |
775 | 1 | 0.01 | what is a oral disintegrating tablet |
776 | 1 | 0.01 | lepidium sativum |
777 | 1 | 0.01 | journal of pharmaceutical |
778 | 1 | 0.01 | knowledge, attitude and practice (kap) s... |
779 | 1 | 0.01 | low c3 and low c4 and thrombocytopenia |
780 | 1 | 0.01 | low complement c2 and c4 levels in sle |
781 | 1 | 0.01 | sarreshtehdari, 2012, diabetes, magnesi... |
782 | 1 | 0.01 | piper crocatum ruiz and pav, hyperglycem... |
783 | 1 | 0.01 | production and evaluation of controlled ... |
784 | 1 | 0.01 | melting point of eudrajit rl100 |
785 | 1 | 0.01 | nigeria journal of pharmaceutical resea... |
786 | 1 | 0.01 | health care seeking practice of care giv... |
787 | 1 | 0.01 | journal contain of artocarpus altilis |
788 | 1 | 0.01 | http://www.tjpr.org/vol4_no2/425ohwoavwo... |
789 | 1 | 0.01 | meloxicam solution stability |
790 | 1 | 0.01 | a dose of 5000 mg/kg frc administered to... |
791 | 1 | 0.01 | antibiotics and caffiene |
792 | 1 | 0.01 | trop j pharm res, june 2010 |
793 | 1 | 0.01 | ethanol induced ulceration pdf |
794 | 1 | 0.01 | glomerulonephritis with low c4 and norma... |
795 | 1 | 0.01 | increase and low c3/c4 |
796 | 1 | 0.01 | c3 c4 complement |
797 | 1 | 0.01 | brucellosis jaundice picture |
798 | 1 | 0.01 | assay of chloroquine phosphate using non... |
799 | 1 | 0.01 | www,tjpr.com |
800 | 1 | 0.01 | the art of drug synthesis pdf |
801 | 1 | 0.01 | what is the significance of increased in... |
802 | 1 | 0.01 | validation of pharmaceutical |
803 | 1 | 0.01 | where can i get priprobit program |
804 | 1 | 0.01 | nanotechnology article pdf |
805 | 1 | 0.01 | how often should c3 and c4 complement le... |
806 | 1 | 0.01 | knowledge of type ii diabetes in nigeria |
807 | 1 | 0.01 | pdfresearch article on ampicillin |
808 | 1 | 0.01 | pdf of physical properties of sodium sta... |
809 | 1 | 0.01 | pharmaceutical validations |
810 | 1 | 0.01 | pharmaceutical tropical journal of pharm... |
811 | 1 | 0.01 | wistar rats and wild dioscorea dumetoriu... |
812 | 1 | 0.01 | uniben pharmacy department |
813 | 1 | 0.01 | piperine plasma studies limit of detecti... |
814 | 1 | 0.01 | evaluation nsaid drug use pdf |
815 | 1 | 0.01 | flavonoids as antifungal agent.pdf |
816 | 1 | 0.01 | journal faculty of pharmacy benin |
817 | 1 | 0.01 | patients perception of services |
818 | 1 | 0.01 | artocarpus altilis medicinal uses |
819 | 1 | 0.01 | anti diarrhoeal activity |
820 | 1 | 0.01 | antimicrobial activity of heracleum |
821 | 1 | 0.01 | "effect of feronia elephantum (corr) fru... |
822 | 1 | 0.01 | c3 c4 levels normal values |
823 | 1 | 0.01 | according to research,are there poisonou... |
824 | 1 | 0.01 | extraction with water and etyl acetate q... |
825 | 1 | 0.01 | caregivers knowledge of malaria |
826 | 1 | 0.01 | caryophyllen |
827 | 1 | 0.01 | formulation of vaginal suppositories in... |
828 | 1 | 0.01 | health related associated to the consump... |
829 | 1 | 0.01 | journal co precipitation and complexatio... |
830 | 1 | 0.01 | http://www.tjpr.org/vol11_no3/index.php |
831 | 1 | 0.01 | drug release vitreous model in vitro |
832 | 1 | 0.01 | differential diagnosis of low c3 |
833 | 1 | 0.01 | drug validation |
834 | 1 | 0.01 | review article on validation of equipmen... |
835 | 1 | 0.01 | qa validation in pharma |
836 | 1 | 0.01 | review article on hplc method developmen... |
837 | 1 | 0.01 | why people use herbal and orthodox medic... |
838 | 1 | 0.01 | transdermal.pdf |
839 | 1 | 0.01 | challenges facing herbal medicine |
840 | 1 | 0.01 | http://www.tjpr.org/vol8_no1/2009_8_1_10... |
841 | 1 | 0.01 | http://www.tjpr.org/vol7_no4/747_jayaram... |
842 | 1 | 0.01 | determanation mobic by spectrophotometer... |
843 | 1 | 0.01 | dissolution of artemether and lumefantri... |
844 | 1 | 0.01 | methods for preparing polymeric micelles |
845 | 1 | 0.01 | is sodium a electron donor or acceptor |
846 | 1 | 0.01 | advantage of using microcrystalline cell... |
847 | 1 | 0.01 | "development of sustained-release microb... |
848 | 1 | 0.01 | transdermal enhancer |
849 | 1 | 0.01 | williams ac bw. penetration enhancers.ad... |
850 | 1 | 0.01 | kap survey |
851 | 1 | 0.01 | new product development pharmaceutical p... |
852 | 1 | 0.01 | complexation by kneading |
853 | 1 | 0.01 | gloriosa superba uses in system of medic... |
854 | 1 | 0.01 | screeing, isolation and characterization... |
855 | 1 | 0.01 | anticonvulsant activity of plant extract |
856 | 1 | 0.01 | an overview on future trends in oral for... |
857 | 1 | 0.01 | tropi j of pharmaceutical res |
858 | 1 | 0.01 | sodium alginate beads pdf |
859 | 1 | 0.01 | pdf on reserpine |
860 | 1 | 0.01 | orally disintegrating tablets |
861 | 1 | 0.01 | preparation of different extraction of g... |
862 | 1 | 0.01 | photoprotective effect of tea and its ex... |
863 | 1 | 0.01 | radius of gyration mutation rg |
864 | 1 | 0.01 | classification of amura plant starch |
865 | 1 | 0.01 | antidiarrhoeal models in rats |
866 | 1 | 0.01 | abstract :liposome drug delivery filetyp... |
867 | 1 | 0.01 | artemether and lumefantrine tablets hard... |
868 | 1 | 0.01 | how can pharmacists increase involvement... |
869 | 1 | 0.01 | nutritional composition of stevia rebaud... |
870 | 1 | 0.01 | milkpasteurizationinnigeria |
871 | 1 | 0.01 | mass spectrometry |
872 | 1 | 0.01 | multiparticulate dosage form |
873 | 1 | 0.01 | gloriosa superba actions |
874 | 1 | 0.01 | design and development of halogenated ch... |
875 | 1 | 0.01 | flurbiprofen molecular weight pdf |
876 | 1 | 0.01 | isolation and identification bacterium... |
877 | 1 | 0.01 | manufacturers of phenolphthalein in u.s.... |
878 | 1 | 0.01 | staphylococcus aureus isolate from urine... |
879 | 1 | 0.01 | praparation of metronidazole floating gr... |
880 | 1 | 0.01 | pharmaceutical technology december 2002 |
881 | 1 | 0.01 | taha a.a naji |
882 | 1 | 0.01 | uv absorption of losartan potassium |
883 | 1 | 0.01 | validation of pharmaceutical equipments |
884 | 1 | 0.01 | nano drug delivery:pdf |
885 | 1 | 0.01 | conclusion of research on the characteri... |
886 | 1 | 0.01 | low complement c3 normal c4 |
887 | 1 | 0.01 | bioencapsulation pharmaceutical |
888 | 1 | 0.01 | aortic ring contraction assay carbamylch... |
889 | 1 | 0.01 | complement c3 and lupus |
890 | 1 | 0.01 | validation in pharma pdf |
891 | 1 | 0.01 | 2 |
892 | 1 | 0.01 | what is validation in pharmaceutical def... |
893 | 1 | 0.01 | antifungal activity in 2014 |
894 | 1 | 0.01 | gdf-8 |
895 | 1 | 0.01 | lupus nephritis serum complement |
896 | 1 | 0.01 | eudragit rl 100 microspheres |
897 | 1 | 0.01 | method developement report for theophyll... |
898 | 1 | 0.01 | newbouldia laevis bark does what. |
899 | 1 | 0.01 | raw material in requirements for re... |
900 | 1 | 0.01 | silymarin pdf |
901 | 1 | 0.01 | physical chemical propefties of tranderm... |
902 | 1 | 0.01 | half life of silymarin in body |
903 | 1 | 0.01 | chalcone anticancer agents |
904 | 1 | 0.01 | epidemiology of venomous snakebite in ni... |
905 | 1 | 0.01 | review papers on stevia rebaudiana |
906 | 1 | 0.01 | oral controlea release drug delivery sys... |
907 | 1 | 0.01 | can diphenydramine undergo direct compre... |
908 | 1 | 0.01 | : professor (mrs) dn onwukaeme |
909 | 1 | 0.01 | cassia occidentalis family pdf |
910 | 1 | 0.01 | isolation, characterization, and anti-m... |
911 | 1 | 0.01 | tropical |
912 | 1 | 0.01 | t tj pr |
913 | 1 | 0.01 | antimicrobial properties of flavonoids |
914 | 1 | 0.01 | pptcontrolled release vs immediate rele... |
915 | 1 | 0.01 | &si=217923 |
916 | 1 | 0.01 | bcg/lps induced liver damage in rats |
917 | 1 | 0.01 | complement levels in lupus |
918 | 1 | 0.01 | study of arformoterol tartrate inhalatio... |
919 | 1 | 0.01 | pseudomonas resistant to dmdm |
920 | 1 | 0.01 | nano drug delivery review: pdf |
921 | 1 | 0.01 | measurement of c3 and c4 |
922 | 1 | 0.01 | pharmres tablets |
923 | 1 | 0.01 | dissolution for artemether,lumefantrine ... |
924 | 1 | 0.01 | attribute medicinal quercus |
925 | 1 | 0.01 | good manufacturing practice in validatio... |
926 | 1 | 0.01 | tooth paste that doesn't contain sodium ... |
927 | 1 | 0.01 | prostate cancer lupeol |
928 | 1 | 0.01 | silliver silymarin 200mg tablets |
929 | 1 | 0.01 | pdf file for future challenges pharmac... |
930 | 1 | 0.01 | pharmaceutical validation and its types |
931 | 1 | 0.01 | application of nanotechnology in pharmac... |
932 | 1 | 0.01 | alkyd resin chemistry pdf |
933 | 1 | 0.01 | assay of cloroquine phosphate using non ... |
934 | 1 | 0.01 | solubility of ciprofloxacin journals |
935 | 1 | 0.01 | installerex official website?q=installer... |
936 | 1 | 0.01 | reserpine is an alkaloid |
937 | 1 | 0.01 | http://www.tjpr.org/jmanager/manuscript/... |
938 | 1 | 0.01 | fda report on microbial load of yoghurt |
939 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
940 | 1 | 0.01 | deinoxanthin |
941 | 1 | 0.01 | c3 and c4 levels |
942 | 1 | 0.01 | diary biotechnology analysis of milk and... |
943 | 1 | 0.01 | diagnosis for complement c4 serum |
944 | 1 | 0.01 | c4 level reduced in |
945 | 1 | 0.01 | anticancer pdf |
946 | 1 | 0.01 | what is the disadvantage of administrati... |
947 | 1 | 0.01 | trop journal pharm res |
948 | 1 | 0.01 | β-lactamase flavonoids |
949 | 1 | 0.01 | drugs preparation of nanotecnology |
950 | 1 | 0.01 | chalcones cancer |
951 | 1 | 0.01 | cristina romeo teodor citations |
952 | 1 | 0.01 | filetype:pdf toxicology studies rhizome ... |
953 | 1 | 0.01 | effect of growth regulators and culture ... |
954 | 1 | 0.01 | msds arformoterol tartrate |
955 | 1 | 0.01 | floating material in drug delivery |
956 | 1 | 0.01 | duro-tak87-202a |
957 | 1 | 0.01 | determination of free doxorubicin in hum... |
958 | 1 | 0.01 | artocarpus heterophyllus chemical consti... |
959 | 1 | 0.01 | can pharmacist paractice in pakistan |
960 | 1 | 0.01 | benin city water supply |
961 | 1 | 0.01 | ccl4 hepatotoxicity mice |
962 | 1 | 0.01 | drugs in odt technology manufacturers in... |
963 | 1 | 0.01 | inayat gul.vol.11 |
964 | 1 | 0.01 | antidiarrheal activity of medicinal plan... |
965 | 1 | 0.01 | &ptb=d1bec8ee-5fe4-4fa2-860c-94c51a6e4b3... |
966 | 1 | 0.01 | stability indicating method by hplc |
967 | 1 | 0.01 | seleman drugs |
968 | 1 | 0.01 | the synthesis of derivatives of chalcone |
969 | 1 | 0.01 | synergestic inhibitory effect of newbuld... |
970 | 1 | 0.01 | "jiangnan university" "j jin" |
971 | 1 | 0.01 | 1xd8p4txohv7tweemyfwdmtpd81sio5jjvliyjiq... |
972 | 1 | 0.01 | tropical pharmaceutical |
973 | 1 | 0.01 | research articles on controlled release... |
974 | 1 | 0.01 | tropical journal o |
975 | 1 | 0.01 | trop j pharm res impact factor |
976 | 1 | 0.01 | tropical journal of pharmaceutical journ... |
977 | 1 | 0.01 | pharmaceutical sciences recent novel rev... |
978 | 1 | 0.01 | nanoparticles – a review. tropical jou... |
979 | 1 | 0.01 | paediatric patients, hazard of administe... |
980 | 1 | 0.01 | systemic lupus exacerbation c3 c4 |
981 | 1 | 0.01 | psychology and low complement levels |
982 | 1 | 0.01 | the surfactants affect the drug release ... |
983 | 1 | 0.01 | fraction extract ic50 t47d breast cancer... |
984 | 1 | 0.01 | emulsion-gelation method for preparing p... |
985 | 1 | 0.01 | formulation & evaluation of fast dissolv... |
986 | 1 | 0.01 | benefits of pharmaceutical care to profe... |
987 | 1 | 0.01 | assay of chloroquine phosphate using non... |
988 | 1 | 0.01 | crosslinking polymer |
989 | 1 | 0.01 | microorganisms contaimination of herbal ... |
990 | 1 | 0.01 | pharmacological activities of bolivia |
991 | 1 | 0.01 | p21 hl60 mcf-7 |
992 | 1 | 0.01 | niosome rifampin"cancer" |
993 | 1 | 0.01 | material control in pharma manufacturing |
994 | 1 | 0.01 | lupus c3 |
995 | 1 | 0.01 | mic of plant extracts protocol |
996 | 1 | 0.01 | method validation of drugs using uv spec... |
997 | 1 | 0.01 | cleaning validation protocol for formula... |
998 | 1 | 0.01 | benin city ground water |
999 | 1 | 0.01 | chalcones as anticancer agents review |
1000 | 1 | 0.01 | who on co-administration of drugs and he... |
1001 | 1 | 0.01 | home treatment of malaria among mothers ... |
1002 | 1 | 0.01 | green cleaning practice in nigerian nati... |
1003 | 1 | 0.01 | pharmaceutical stability standard operat... |
1004 | 1 | 0.01 | latest on antimicrobial activity of medi... |
1005 | 1 | 0.01 | drug compliance among hypertensive |
1006 | 1 | 0.01 | current drug delivery system for captopr... |
1007 | 1 | 0.01 | jurnal reserpin pdf |
1008 | 1 | 0.01 | tropical journal of pharmaceuticalt scie... |
1009 | 1 | 0.01 | rhyzopertha dominica essential oil |
1010 | 1 | 0.01 | trop j pharm?query=trop j pharm |
1011 | 1 | 0.01 | chloroquin phosphate tablet pdf |
1012 | 1 | 0.01 | to determine the method of isoniazid usi... |
1013 | 1 | 0.01 | preparation and evaluation of microspong... |
1014 | 1 | 0.01 | role of serum c3 estimation |
1015 | 1 | 0.01 | validation pharma checking |
1016 | 1 | 0.01 | tropical evaluation of creams |
1017 | 1 | 0.01 | wavelength of rifampin |
1018 | 1 | 0.01 | guillaume f. guyot-hermann am guyot jc. ... |
1019 | 1 | 0.01 | gastroretentive systems |
1020 | 1 | 0.01 | chemical contents of carpolobia lutea |
1021 | 1 | 0.01 | cd level reference benin |
1022 | 1 | 0.01 | erianin inflammation |
1023 | 1 | 0.01 | advantages of muliparticulates |
1024 | 1 | 0.01 | assay of chloroquine phosphate using non... |
1025 | 1 | 0.01 | c3 & c4 count |
1026 | 1 | 0.01 | preparation and evaluation of solid disp... |
1027 | 1 | 0.01 | pharmacokinetic study of a capsule-ba... |
1028 | 1 | 0.01 | patented technologies for fast dissolvin... |
1029 | 1 | 0.01 | pharmaceutical process validation sop |
1030 | 1 | 0.01 | triclosan journal articles |
1031 | 1 | 0.01 | sambucus ebulus |
1032 | 1 | 0.01 | tropical journal of pharmacology |
1033 | 1 | 0.01 | www.antimicrobial property of hibiscus s... |
1034 | 1 | 0.01 | diuretic effect of plant pdf |
1035 | 1 | 0.01 | c3 and c4 autoimmune profile low |
1036 | 1 | 0.01 | patients’ assessment of pharmacists’... |
1037 | 1 | 0.01 | patient waiting time |
1038 | 1 | 0.01 | tablet gastroretentive swelling |
1039 | 1 | 0.01 | natural remedies challenges |
1040 | 1 | 0.01 | nanotechnology applications in drug deli... |
1041 | 1 | 0.01 | drug prescription pattern in a nigerian ... |
1042 | 1 | 0.01 | orodisperdible tablets |
1043 | 1 | 0.01 | newbouldia laevis |
1044 | 1 | 0.01 | natural toothpaste ingredients pdf |
1045 | 1 | 0.01 | knowledge of under five mothers about ma... |
1046 | 1 | 0.01 | herbal toothpaste.pdf |
1047 | 1 | 0.01 | extract aqueous antioxidant of psidium g... |
1048 | 1 | 0.01 | impact on hardness of compressed tablet ... |
1049 | 1 | 0.01 | antimicrobial.activities of medicinal pl... |
1050 | 1 | 0.01 | zhang yan, shen tingting, liu suwen, zha... |
1051 | 1 | 0.01 | essential oil |
1052 | 1 | 0.01 | excel cell column keyword abstract issn ... |
1053 | 1 | 0.01 | drug manufacture validation |
1054 | 1 | 0.01 | drotaverine hydrochloride tablets solubi... |
1055 | 1 | 0.01 | 10.15289 |
1056 | 1 | 0.01 | can a dispenser practise in pak |
1057 | 1 | 0.01 | f9f5b81bc72512138309b3864258f1fa |
1058 | 1 | 0.01 | antifungal activity of plant extracts ag... |
1059 | 1 | 0.01 | c4 serum low |
1060 | 1 | 0.01 | effect of calcium chloride on the prepa... |
1061 | 1 | 0.01 | validation process pdf |
1062 | 1 | 0.01 | "dendrobium" isolation 2014 |
1063 | 1 | 0.01 | sle c3 c4 |
1064 | 1 | 0.01 | phytochemical ancinalalysis of medicina... |
1065 | 1 | 0.01 | project report on sustain release microp... |
1066 | 1 | 0.01 | thin layer chromatography of antibiotics... |
1067 | 1 | 0.01 | standard tests and limits in pharmaceuti... |
1068 | 1 | 0.01 | formalution and evalution of tramadol hy... |
1069 | 1 | 0.01 | factors affecting penetration enhancer |
1070 | 1 | 0.01 | complement in sle |
1071 | 1 | 0.01 | challenges in carrying out pharmaceutica... |
1072 | 1 | 0.01 | dimethylsulfoxide penetration enhancer |
1073 | 1 | 0.01 | penetration technology for chemicals |
1074 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
1075 | 1 | 0.01 | isolation of pathogens from urine |
1076 | 1 | 0.01 | tropical journal of pharmacy |
1077 | 1 | 0.01 | prevalence of e.coli among uti patients |
1078 | 1 | 0.01 | what is the best absorbed form of natura... |
1079 | 1 | 0.01 | lauric acid and propylene glycol penetra... |
1080 | 1 | 0.01 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
1081 | 1 | 0.01 | apoptosis mtt assay |
1082 | 1 | 0.01 | analgesic abuse in nigeria pdf |
1083 | 1 | 0.01 | anticonvulsant pdf |
1084 | 1 | 0.01 | compliment c3 |
1085 | 1 | 0.01 | azone and drug |
1086 | 1 | 0.01 | ground water hydrology in benin city, ed... |
1087 | 1 | 0.01 | sample research proposal+analytical meth... |
1088 | 1 | 0.01 | reason why patients cannot take donepezi... |
1089 | 1 | 0.01 | reference style in pharma researh paper |
1090 | 1 | 0.01 | plant extract |
1091 | 1 | 0.01 | onyekweli in uniben pharmacy |
1092 | 1 | 0.01 | tropical medical journal of pharmaceutic... |
1093 | 1 | 0.01 | tablet coating |
1094 | 1 | 0.01 | amoxicillin caffeine |
1095 | 1 | 0.01 | types of transmucosal drug delivery, pd... |
1096 | 1 | 0.01 | ana positive and low c4 c3 normal |
1097 | 1 | 0.01 | c3 levels normal |
1098 | 1 | 0.01 | why the extracts did not show any antimi... |
1099 | 1 | 0.01 | synthesis scheme for 2,3-disubstitued qu... |
1100 | 1 | 0.01 | pulsatile drug delivery system for rheum... |
1101 | 1 | 0.01 | venumous reptiles of northern nigeria |
1102 | 1 | 0.01 | malaria structural bioinformatics biolog... |
1103 | 1 | 0.01 | lepedium sativum |
1104 | 1 | 0.01 | low c4 normal c3 |
1105 | 1 | 0.01 | phytochemical analysis of newbouldia lae... |
1106 | 1 | 0.01 | phenolphthalein laxative |
1107 | 1 | 0.01 | possible uti pathogen pdf |
1108 | 1 | 0.01 | can diethyl ether cause cancer |
1109 | 1 | 0.01 | c4 complement of 52 |
1110 | 1 | 0.01 | clinical manifestations of human brucell... |
1111 | 1 | 0.01 | drug permeation through skin ppt |
1112 | 1 | 0.01 | legal limit for alcohol in nigeria |
1113 | 1 | 0.01 | research article on complements levels |
1114 | 1 | 0.01 | poisonous snakes of northern nigeria |
1115 | 1 | 0.01 | j aukunuru; email |
1116 | 1 | 0.01 | toothpaste pdf?q=toothpaste pdf |
1117 | 1 | 0.01 | validation techniques for pharmaceutical... |
1118 | 1 | 0.01 | lupus nephritic c3 |
1119 | 1 | 0.01 | http://www.tjpr.org/vol1%20no2/erah12b.p... |
1120 | 1 | 0.01 | effect of zeta potential on the properti... |
1121 | 1 | 0.01 | graph of particle size analysis of micro... |
1122 | 1 | 0.01 | niosome formulation for transdermal drug... |
1123 | 1 | 0.01 | major phases of validation pdf |
1124 | 1 | 0.01 | skin penetration enhancers |
1125 | 1 | 0.01 | stability indicating reverse phase hplc ... |
1126 | 1 | 0.01 | medicinal plants amino acid analysis |
1127 | 1 | 0.01 | orodispersible tablet by ordinary excipi... |
1128 | 1 | 0.01 | in process and finished product quality ... |
1129 | 1 | 0.01 | eudragit used n osmotic tablet |
1130 | 1 | 0.01 | ethyl group |
1131 | 1 | 0.01 | formulation and evaluation of immediate ... |
1132 | 1 | 0.01 | southern sonora mexico |
1133 | 1 | 0.01 | spectrophotometric analysis of cilostazo... |
1134 | 1 | 0.01 | purification of mefenamic acid |
1135 | 1 | 0.01 | challenges of herbal medicine |
1136 | 1 | 0.01 | yarmouk university al-jassabi |
1137 | 1 | 0.01 | tjpr |
1138 | 1 | 0.01 | culture vs underfive malaria pdf |
1139 | 1 | 0.01 | dynamics gromacs |
1140 | 1 | 0.01 | aceclofenac solubility in oils |
1141 | 1 | 0.01 | trolamine salicylate method of action |
1142 | 1 | 0.01 | validation of pharmaceutical equpiment a... |
1143 | 1 | 0.01 | traditional/herbal medicine cultures in ... |
1144 | 1 | 0.01 | microbial analysis of used toothbrush. p... |
1145 | 1 | 0.01 | mucin drug |
1146 | 1 | 0.01 | modern trends in ethnobotany |
1147 | 1 | 0.01 | chalcone |
1148 | 1 | 0.01 | aquifer formations in edo state (benin c... |
1149 | 1 | 0.01 | artesunate and amodiaquine 25mg/75mg tab... |
1150 | 1 | 0.01 | african journal of pharmaceutics |
1151 | 1 | 0.01 | accuracy of the electron donor record in... |
1152 | 1 | 0.01 | effect of herbal purgative on intestinal... |
1153 | 1 | 0.01 | drugs know 9 avtaar |
1154 | 1 | 0.01 | experiment on the investigation of antic... |
1155 | 1 | 0.01 | female osteoporosis |
1156 | 1 | 0.01 | process validation in pharmaceuticals |
1157 | 1 | 0.01 | patents on drug delivery & formulation p... |
1158 | 1 | 0.01 | professor obianwu hope |
1159 | 1 | 0.01 | alginate chiosan beads dsc |
1160 | 1 | 0.01 | chitosan microspheres pdf |
1161 | 1 | 0.01 | international journal of biological & ph... |
1162 | 1 | 0.01 | method of crude extraction pdf |
1163 | 1 | 0.01 | uses of arqe badiyan |
1164 | 1 | 0.01 | transdermal chemical |
1165 | 1 | 0.01 | tropical j of pharmaceutical research |
1166 | 1 | 0.01 | terminalia glaucescens |
1167 | 1 | 0.01 | transdermal absorption increase |
1168 | 1 | 0.01 | anticholinesterase extract |
1169 | 1 | 0.01 | validation of equipment in pharmaceutica... |
1170 | 1 | 0.01 | validation of pharmaceutical process |
1171 | 1 | 0.01 | c4 complement |
1172 | 1 | 0.01 | validation of manufacturing |
1173 | 1 | 0.01 | study on the characterization and contro... |
1174 | 1 | 0.01 | www.c u uinebase |
1175 | 1 | 0.01 | oral disintegrating tablets pdf |
1176 | 1 | 0.01 | nigeria venomous snakes |
1177 | 1 | 0.01 | ondansetron transdermal patch |
1178 | 1 | 0.01 | roles of pharmacist at primary health ca... |
1179 | 1 | 0.01 | carica papayaleaf extract contain |
1180 | 1 | 0.01 | g asuntha, y prasannaraju and kvsrg pras... |
1181 | 1 | 0.01 | tropical journal of pharmaceutical rese... |
1182 | 1 | 0.01 | http://www.tjpr.org/vol8_no3/2009_8_3_5_... |
1183 | 1 | 0.01 | hydrophobic excipients list pdf |
1184 | 1 | 0.01 | myristica fragrans in atherosclerosis |
1185 | 1 | 0.01 | meloxicam rp hplc methods |
1186 | 1 | 0.01 | nanotechnology in drug delivery |
1187 | 1 | 0.01 | cyp2d6 china |
1188 | 1 | 0.01 | caffeine antibacterial |
1189 | 1 | 0.01 | complement c3 and c4 normal levels |
1190 | 1 | 0.01 | behzad sharif makhmalzadeh |
1191 | 1 | 0.01 | aspergillus oryzae brine shrimp lethalit... |
1192 | 1 | 0.01 | study on self medication in rural and ur... |
1193 | 1 | 0.01 | treatment of anti convulsant activity pd... |
1194 | 1 | 0.01 | description of mitracarpus scaber zucc |
1195 | 1 | 0.01 | tropical journal of pharmaceutival journ... |
1196 | 1 | 0.01 | "methyl jasmonate" cancer |
1197 | 1 | 0.01 | oleic acid penetration enhancer |
1198 | 1 | 0.01 | methanol extract |
1199 | 1 | 0.01 | farnesal gc/ms |
1200 | 1 | 0.01 | megace nano review |
1201 | 1 | 0.01 | pdf on why do people self medicate |
1202 | 1 | 0.01 | sustained release tablets formulation |
1203 | 1 | 0.01 | validation in pharmacy |
1204 | 1 | 0.01 | waiting time outpatient pharmacy |
1205 | 1 | 0.01 | barry finnin |
1206 | 1 | 0.01 | definition of critical and key raw mater... |
1207 | 1 | 0.01 | side effects of artemisinin combination ... |
1208 | 1 | 0.01 | recent trends in ethanobotany |
1209 | 1 | 0.01 | researches on drug-drug interaction on p... |
1210 | 1 | 0.01 | tropical journal of pharmacwutics |
1211 | 1 | 0.01 | solid dispersions review pdf |
1212 | 1 | 0.01 | a manual of ethnobotany |
1213 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
1214 | 1 | 0.01 | dmso enhances transdermal permeation |
1215 | 1 | 0.01 | drug delivery nanotechnology availabilit... |
1216 | 1 | 0.01 | bioactive bibenzyl derivatives and fluor... |
1217 | 1 | 0.01 | average waiting time in a pharmacy |
1218 | 1 | 0.01 | diaz am, abad mj, fernandez l, silvan am... |
1219 | 1 | 0.01 | ogba and ikpoba river on contamination o... |
1220 | 1 | 0.01 | journal bioavailability and bioequivalen... |
1221 | 1 | 0.01 | malaria medication alu and pregnancy |
1222 | 1 | 0.01 | pharmaceutical approaches of drug loaded... |
1223 | 1 | 0.01 | &si=cp6wte71hbmcfufb3godcgkayg |
1224 | 1 | 0.01 | validation pharma |
1225 | 1 | 0.01 | &ptb=6b16e2d2-a2e1-4480-9dd1-0ebd1218df5... |
1226 | 1 | 0.01 | sesamum indicum |
1227 | 1 | 0.01 | herbal drugs: challenges and opportuniti... |
1228 | 1 | 0.01 | http://www.tjpr.org/vol12_no6/2013_12_6_... |
1229 | 1 | 0.01 | osteoporosis health belief model knowled... |
1230 | 1 | 0.01 | penetration enhancers pdf |
1231 | 1 | 0.01 | double emulsion method microspheres |
1232 | 1 | 0.01 | chemical hepatic injury induced by ccl4 |
1233 | 1 | 0.01 | assessment of adherence to art in benin ... |
1234 | 1 | 0.01 | formulation development & optimization o... |
1235 | 1 | 0.01 | extracellular enzyme by actinomycetes |
1236 | 1 | 0.01 | methods of screening of diuretic drugs |
1237 | 1 | 0.01 | about antipyretic analgesics.pdf |
1238 | 1 | 0.01 | 088b7d9347ec185e17882580c3a3d62a |
1239 | 1 | 0.01 | lower to upper percentage of dimethyl f... |
1240 | 1 | 0.01 | isothiocyanate |
1241 | 1 | 0.01 | nsaid abuse in students |
1242 | 1 | 0.01 | nanotechnology drugs pdf |
1243 | 1 | 0.01 | process validation pdf |
1244 | 1 | 0.01 | diazepam indomethazine mixture |
1245 | 1 | 0.01 | daunorubicin related compound hplc |
1246 | 1 | 0.01 | brucellosis treatment saudi arabia |
1247 | 1 | 0.01 | alkyd resins structure and its preparati... |
1248 | 1 | 0.01 | cefuroxime axetil solubility in differen... |
1249 | 1 | 0.01 | hilda rastegari |
1250 | 1 | 0.01 | effect of toothpaste on bacteria pdf |
1251 | 1 | 0.01 | introduction about tea consumption affec... |
1252 | 1 | 0.01 | http://www.tjpr.org/vol11_no5/index.php |
1253 | 1 | 0.01 | irinotecan hydrochloride in india banglo... |
1254 | 1 | 0.01 | definition of validation in pharmaceutic... |
1255 | 1 | 0.01 | validation in pharma company?q=validatio... |
1256 | 1 | 0.01 | www.pharmacutical dissolution an of tabl... |
1257 | 1 | 0.01 | small ppt on chronotherapeutics |
1258 | 1 | 0.01 | salicylic acid penetration enhancer |
1259 | 1 | 0.01 | green tea health in pdf |
1260 | 1 | 0.01 | how targeting is acheived in mucoadhesiv... |
1261 | 1 | 0.01 | pharmqcopial limits of oral disintegrati... |
1262 | 1 | 0.01 | phytochemical screening of delphinium aj... |
1263 | 1 | 0.01 | pdf of minitablets disadvantages |
1264 | 1 | 0.01 | method development and validation of gen... |
1265 | 1 | 0.01 | microorganism isolated from pasteurized ... |
1266 | 1 | 0.01 | springer pharmacy journals |
1267 | 1 | 0.01 | pharmacy journals in science citation in... |
1268 | 1 | 0.01 | ?searchfor=multiparticulates |
1269 | 1 | 0.01 | sodium cyclamate used in pharmaceutical ... |
1270 | 1 | 0.01 | penetration enhancers for transdermal dr... |
1271 | 1 | 0.01 | knowledge of malaria prevention strateg... |
1272 | 1 | 0.01 | calcium sennosides a & b powder recommen... |
1273 | 1 | 0.01 | 4) thombre ag, appel le, chidlaw mb, dau... |
1274 | 1 | 0.01 | aduruku of newbouldia laevis |
1275 | 1 | 0.01 | ethnobotany in human welfare |
1276 | 1 | 0.01 | pharmaceutical journals in uae |
1277 | 1 | 0.01 | orally disintegrating tablets a review |
1278 | 1 | 0.01 | low c reactive protein and c3 c4 |
1279 | 1 | 0.01 | liquid chromatographic determination pdf |
1280 | 1 | 0.01 | malaysia |
1281 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
1282 | 1 | 0.01 | satya prakash singh, ch.niranjan patra, ... |
1283 | 1 | 0.01 | trop j of phar res |
1284 | 1 | 0.01 | what type of tablet paking in plastic co... |
1285 | 1 | 0.01 | validation as regards to pharmaceutical ... |
1286 | 1 | 0.01 | garcinia interactions |
1287 | 1 | 0.01 | basics of biochips and microarray techn... |
1288 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
1289 | 1 | 0.01 | tropical j pharmaceutical research |
1290 | 1 | 0.01 | what are the problems of septic tank in ... |
1291 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
1292 | 1 | 0.01 | why is non aqueous titration used for as... |
1293 | 1 | 0.01 | www.pharmacutical mass transport and dis... |
1294 | 1 | 0.01 | synthesis of benzoic acid hydrazide |
1295 | 1 | 0.01 | journal of oil palm research |
1296 | 1 | 0.01 | antidiarrheal activity of herbal plants ... |
1297 | 1 | 0.01 | erigeron floribundus+biological activity... |
1298 | 1 | 0.01 | treatment patern of of hypertensive di... |
1299 | 1 | 0.01 | swietenia macrophylla anup maiti pdf |
1300 | 1 | 0.01 | the use of antipyretic analgesics.pdf |
1301 | 1 | 0.01 | matrix tablets of ispaghol uses |
1302 | 1 | 0.01 | medicinal plants traded from nigeria |
1303 | 1 | 0.01 | progress in controlled gastroretentive d... |
1304 | 1 | 0.01 | pharmacological action of quercus infect... |
1305 | 1 | 0.01 | serum complement (c3 & c4) |
1306 | 1 | 0.01 | flavanone: pdf |
1307 | 1 | 0.01 | filetype:pdf process validation |
1308 | 1 | 0.01 | dosage of artocarpus lakoocha |
1309 | 1 | 0.01 | c3 sle |
1310 | 1 | 0.01 | effects of herbs on the liver in nigeria... |
1311 | 1 | 0.01 | journals sultan-ul-uloom college of pha... |
1312 | 1 | 0.01 | liver damage |
1313 | 1 | 0.01 | jurnal tablet sustain release pdf |
1314 | 1 | 0.01 | low serum c3 associated nephritis |
1315 | 1 | 0.01 | increase in complement c3 and c4 |
1316 | 1 | 0.01 | average wait time for a prescprition to ... |
1317 | 1 | 0.01 | vincristine analysis by hplc-fluorimetri... |
1318 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
1319 | 1 | 0.01 | venomous snakes nigeria |
1320 | 1 | 0.01 | antimicrobial studies about klebsiella p... |
1321 | 1 | 0.01 | average pharmacy wait time |
1322 | 1 | 0.01 | native snakes of nigeria |
1323 | 1 | 0.01 | method of preparation of microcapsules |
1324 | 1 | 0.01 | low c3 complement and normal c4 |
1325 | 1 | 0.01 | mefenamic acid a review article |
1326 | 1 | 0.01 | sociodemographic characteristics of heal... |
1327 | 1 | 0.01 | prospective validation in pharma |
1328 | 1 | 0.01 | the role of a community pharmacist in pr... |
1329 | 1 | 0.01 | antibacterial treapy niosome filetype:pd... |
1330 | 1 | 0.01 | http://www.tjpr.org/vol12_no5/2013_12_5_... |
1331 | 1 | 0.01 | formulation evaluation lamivudine micros... |
1332 | 1 | 0.01 | activity antioxidant ziziphus obtusifoli... |
1333 | 1 | 0.01 | how to perform change control for pharma... |
1334 | 1 | 0.01 | pharmaceutical journal prescription wait... |
1335 | 1 | 0.01 | penetration enhancers for transdermal dr... |
1336 | 1 | 0.01 | preparing polymer micelles |
1337 | 1 | 0.01 | preparation. and evaluation of paracetam... |
1338 | 1 | 0.01 | safety issues related to nano drug deliv... |
1339 | 1 | 0.01 | histopathological effect of ovariectomy... |
1340 | 1 | 0.01 | chemical penetration enhancer transderma... |
1341 | 1 | 0.01 | general procedure for synthesis of schif... |
1342 | 1 | 0.01 | antimicrobial assay: minimum inhibitory ... |
1343 | 1 | 0.01 | cache:http://www.tjpr.org/vol13_no3/2014... |
1344 | 1 | 0.01 | ipqc tests for all pharmaceutical produc... |
1345 | 1 | 0.01 | liquid chromatography zidovudine |
1346 | 1 | 0.01 | validation of pharmacetical equipment pd... |
1347 | 1 | 0.01 | salahsalimizadeh |
1348 | 1 | 0.01 | tropical jouranal of pharmaceutical scie... |
1349 | 1 | 0.01 | multiparticulate drug delivery |
1350 | 1 | 0.01 | nepritis with normal c3 |
1351 | 1 | 0.01 | plga microbead drug delivery |
1352 | 1 | 0.01 | role of pharmacist in nigeria |
1353 | 1 | 0.01 | evaluation of unexplained lymphadenopath... |
1354 | 1 | 0.01 | colorimetric method for assay of chloram... |
1355 | 1 | 0.01 | wound healing activity of plant extract ... |
1356 | 1 | 0.01 | what do skin penetrating agents contain? |
1357 | 1 | 0.01 | ast and alp activities were measured wit... |
1358 | 1 | 0.01 | how to determine anticancer property |
1359 | 1 | 0.01 | gas chromatography of essential oils |
1360 | 1 | 0.01 | in vitro anticholinesterase activity of ... |
1361 | 1 | 0.01 | troptropical research of pharmaceutical ... |
1362 | 1 | 0.01 | toxicity shrimp |
1363 | 1 | 0.01 | sustainable development, pharmaceutical ... |
1364 | 1 | 0.01 | tablets oral dosage form indian universi... |
1365 | 1 | 0.01 | phytochemicals of gloriosa superba |
1366 | 1 | 0.01 | reserpine tablets in india |
1367 | 1 | 0.01 | research articles on fast dissolving tab... |
1368 | 1 | 0.01 | saponins extract from terminalia arjuna ... |
1369 | 1 | 0.01 | determination betahistin lc/ms |
1370 | 1 | 0.01 | doctors response time to outpatient |
1371 | 1 | 0.01 | brine shrimp assay test |
1372 | 1 | 0.01 | behzadsharifmakhmalzadeh articles |
1373 | 1 | 0.01 | causes of low c3 and c4 |
1374 | 1 | 0.01 | http://www.tjpr.org/vol10_no4/2011_10_4_... |
1375 | 1 | 0.01 | marine derived fungi antimicrobial activ... |
1376 | 1 | 0.01 | low c3 c4 no ana |
1377 | 1 | 0.01 | ferrous sulphate and folic acid tablets ... |
1378 | 1 | 0.01 | current trends in ethnobotany |
1379 | 1 | 0.01 | agar use in mucoadhesion study for nasal... |
1380 | 1 | 0.01 | /index/detail/id/58.html?s=/index/detail... |
1381 | 1 | 0.01 | betahistine mesylate and betahistine dih... |
1382 | 1 | 0.01 | tapioca elasticity |
1383 | 1 | 0.01 | microspheres preparation |
1384 | 1 | 0.01 | osemene kp, lamikanra a. tropical journa... |
1385 | 1 | 0.01 | validation of pharmaceutical products |
1386 | 1 | 0.01 | penteration enhancers |
1387 | 1 | 0.01 | osteoporosis knowledge |
1388 | 1 | 0.01 | http://www.tjpr.org/vol7_no4/743_hussain... |
1389 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
1390 | 1 | 0.01 | q. infectoria |
1391 | 1 | 0.01 | types of process validation |
1392 | 1 | 0.01 | alkyd resin + paint + review + pdf |
1393 | 1 | 0.01 | antioxidant activity hepatoprotective ac... |
1394 | 1 | 0.01 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
1395 | 1 | 0.01 | duties phamacist perform in the primary ... |
1396 | 1 | 0.01 | estimation of croscarmellose sodium in t... |
1397 | 1 | 0.01 | www.punjab medical faculty lahore dispen... |
1398 | 1 | 0.01 | wijesinghe p r |
1399 | 1 | 0.01 | design development and process validatio... |
1400 | 1 | 0.01 | organisation of retail pharmacy in niger... |
1401 | 1 | 0.01 | tramadol lotion |
1402 | 1 | 0.01 | f saleem discipline of social and admini... |
1403 | 1 | 0.01 | basic criteria for new method developmen... |
1404 | 1 | 0.01 | chalengges in oral thin films |
1405 | 1 | 0.01 | asthma th2 aqueous extract |
1406 | 1 | 0.01 | adverse effect of artemsisnin monotherap... |
1407 | 1 | 0.01 | astragalus injection ameliorates cisplat... |
1408 | 1 | 0.01 | hplc method validation in tropical journ... |
1409 | 1 | 0.01 | good manufacturing practices for pharmac... |
1410 | 1 | 0.01 | gududa decise |
1411 | 1 | 0.01 | introduction to pharmaceutical validatio... |
1412 | 1 | 0.01 | latitude and longitude of oredo local go... |
1413 | 1 | 0.01 | antibacterial activity of toothpaste aga... |
1414 | 1 | 0.01 | thymol mouthwash action |
1415 | 1 | 0.01 | skin absorption enhancers |
1416 | 1 | 0.01 | type of snakes in nigeria |
1417 | 1 | 0.01 | m-pyrrolidone prtition coefficient oleic... |
1418 | 1 | 0.01 | http://www.tjpr.org/vol8_no4/2009_8_4_3_... |
1419 | 1 | 0.01 | introduction of diuretic activity pdf |
1420 | 1 | 0.01 | only elevated c4 levels |
1421 | 1 | 0.01 | nanotechnology and drug delivery part 1:... |
1422 | 1 | 0.01 | simvastatin+hplc |
1423 | 1 | 0.01 | essential oils transdermal delivery syst... |
1424 | 1 | 0.01 | dissolution profile of artemether & lum... |
1425 | 1 | 0.01 | do nicotine patches contain dmso |
1426 | 1 | 0.01 | complement c3 & c4 |
1427 | 1 | 0.01 | behzad sharif makhmal zadeh :citation |
1428 | 1 | 0.01 | formulation and evaluation of metformin ... |
1429 | 1 | 0.01 | formulation for efficacy |
1430 | 1 | 0.01 | hunteria umbellata seed |
1431 | 1 | 0.01 | leech saliva abbas |
1432 | 1 | 0.01 | pharmaceutical process design and manage... |
1433 | 1 | 0.01 | coating effect in pharmaceuticals |
1434 | 1 | 0.01 | doctors perception and expectation punja... |
1435 | 1 | 0.01 | microsphere formulation |
1436 | 1 | 0.01 | knowledge of self medication among gener... |
1437 | 1 | 0.01 | pharmacy journals without publication fe... |
1438 | 1 | 0.01 | pharma validation methods in quality ass... |
1439 | 1 | 0.01 | which azo dye has lambda max of 490 nm |
1440 | 1 | 0.01 | any tropical preparation containing tram... |
1441 | 1 | 0.01 | antitubercular activity |
1442 | 1 | 0.01 | barrier to drug penetration |
1443 | 1 | 0.01 | preparation and evaluation of microspong... |
1444 | 1 | 0.01 | review article on sublingual tablet |
1445 | 1 | 0.01 | plant diuretics. pdf |
1446 | 1 | 0.01 | drug delivery system of catalyst pdf |
1447 | 1 | 0.01 | alt and ast after albumine infusion |
1448 | 1 | 0.01 | formulation tablet extract ethanol psidi... |
1449 | 1 | 0.01 | flower analgesic activity |
1450 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
1451 | 1 | 0.01 | home treatmentt of malaria among under ... |
1452 | 1 | 0.01 | diabetes, papaya, pdf |
1453 | 1 | 0.01 | hepatic complication of the brucellosis |
1454 | 1 | 0.01 | alginate beads pdf |
1455 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
1456 | 1 | 0.01 | chemical quality assessment of some comm... |
1457 | 1 | 0.01 | how to evaporate solvent in formulation |
1458 | 1 | 0.01 | journal development drug delivery cancer... |
1459 | 1 | 0.01 | increased c4 complement |
1460 | 1 | 0.01 | nasal inserts for drug delivery: an over... |
1461 | 1 | 0.01 | protein extraction procedure from actino... |
1462 | 1 | 0.01 | pictures of posinous snakes in nigeria |
1463 | 1 | 0.01 | newbouldia laevis roots.pdf |
1464 | 1 | 0.01 | pdf stability-indicating hplc methods fo... |
1465 | 1 | 0.01 | guangzhou university of "chinese medici... |
1466 | 1 | 0.01 | extraction and chatacterization of micro... |
1467 | 1 | 0.01 | how to augment delivery of testosterone ... |
1468 | 1 | 0.01 | tjpr |
1469 | 1 | 0.01 | what are normal readings for c-3 and c-4... |
1470 | 1 | 0.01 | questionnaire on waiting time and consul... |
1471 | 1 | 0.01 | process validation and development of ph... |
1472 | 1 | 0.01 | serum c3 c4 |
1473 | 1 | 0.01 | dapi+extract+pdf |
1474 | 1 | 0.01 | akerele and ukoh. tropical journal of ph... |
1475 | 1 | 0.01 | drugs are suitable for sustained release... |
1476 | 1 | 0.01 | editor assignment pending |
1477 | 1 | 0.01 | ethnobotany today |
1478 | 1 | 0.01 | contaminants of ground water in edo stat... |
1479 | 1 | 0.01 | advanced drug delivery system in topical... |
1480 | 1 | 0.01 | cefuroximeaxetiltablets |
1481 | 1 | 0.01 | tjpr journal |
1482 | 1 | 0.01 | research on moringa oleifera and alcohol... |
1483 | 1 | 0.01 | process validation in pharmaceutical ind... |
1484 | 1 | 0.01 | limitations of the study on the analyses... |
1485 | 1 | 0.01 | journal of ba be studies on the dosage f... |
1486 | 1 | 0.01 | penetration enhancers for transdermal dr... |
1487 | 1 | 0.01 | sushruta koppula |